Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in

  News Archive

TxCell Receives EUR 1 Million Milestone Payment
Thursday, January 29, 2015
Milestone payment triggered by first patient enrolment in the phase IIb clinical trial for refractory Crohn’s disease.

NIH Launches Tool to Advance Down Syndrome Research
Wednesday, January 28, 2015
Web portal will help approved professionals to plan clinical studies.

UCB Announces US and EU Regulatory Filings for Brivaracetam
Tuesday, January 27, 2015
Major milestone for brivaracetam is latest step towards UCB goal of extending treatment choices for adult epilepsy patients with uncontrolled partial-onset seizures.

HRA and MHRA Welcome Public Consultation
Tuesday, January 27, 2015
Consultation on application of transparency rules of EU Clinical Trial Regulation.

TxCell €1.7M for Crohn’s Disease Study
Tuesday, January 27, 2015
Top line results of this study are expected at the end of 2016 / early 2017.

Dry Eye Syndrome: Neuroptis Successfully Completes the Pre-clinical Phase for ML7
Saturday, January 24, 2015
Neuroptis is looking to establish industrial and financial partnerships to commence human trials.

Aprea Granted European Orphan Drug Designation for APR-246 in Ovarian Cancer
Saturday, January 24, 2015
Company is currently conducting a Phase Ib/II trial of APR-246.

TxCell to Present at the Cell & Gene Therapy Forum 2015
Saturday, January 24, 2015
Company to present its experience with Cell Therapy at the Cell & Gene Therapy Forum 2015, Washington.

Promethera® Biosciences Reshapes its Leadership Team
Saturday, January 24, 2015
Company announces resignation of Eric Halioua from his post as CEO of Promethera.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 3441

SELECTBIO Market Reports
Go to LabTube
Go to eposters